John L. Gilmore

2-Amino-4<i>H</i>-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Sheryl J. Hays, Bradley W. Caprathe, John L. Gilmore et al. · Journal of Medicinal Chemistry · 1998 · 157 citations · Full text

Combinatorial Chemistry, Complement Enzyme C1r, Medicinal Chemistry +14

The design and synthesis of sulfonamides as caspase-1 inhibitors

William G. Harter, Hans Albrect, Kenneth D. Brady et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 57 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Bioorganic Chemistry +7

Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

John L. Gilmore, Bryan W. King, Cathy Harris et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 46 citations · Full text

Structure–activity Relationship, Molecular Pharmacology, Medicinal Chemistry +11

Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)

James E. Sheppeck, John L. Gilmore, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 42 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +8

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

John L. Gilmore, Sheryl J. Hays, Bradley W. Caprathe et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 39 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +6